Furthermore, the correlation of miR-155 and FOXO3 was previously reported in tumors as follows: expression of miR-155 is upregulated in tumors and acts as an oncogene in cancer [36, 37], while expression of FOXO3 is downregulated and can inhibit the development of tumors [38, 39]. Here, FOXO3 is linked to cancer.